Home | Industry & Research | Nanopatch sparks interest at med-tech conference

Nanopatch sparks interest at med-tech conference

An innovative project that will change the way vaccines are delivered to patients sparked the most interest at the AusMedtech conference and investment summit in Sydney. The Vaxxas Nonopatch developed by the University of Queensland is expected to reduce production and storage costs.

Please login below to view content or register for a 4 week FREE Trial.

Membership Login

Get the news delivered straight to your inbox

Receive the top stories in our weekly newsletter Sign up now